NYSE:BTX

Brooklyn Immunotherapeutics Stock Insider Trading

etoro logo Buy BTX
*Your capital is at risk
$8.95
-0.470 (-4.99%)
At Close: Jun 23, 2026

Brooklyn Immunotherapeutics Stock Insider Power

Based on the 8 latest insides trades, we have calculated the insider power to be negative at -99.94. In total, the insiders bought 334.08M and sold 1.21T BTX shares in the last 8 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 8 transactions)
-99.94
Buy 334.08M shares
Sell 1.21T shares
50% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jan 30, 2026
Buy
Phantom Shares
A-Award
Menge Steven Reid
Portfolio Manager
Other 4 137
Value: $27.6K
Jan 30, 2026
Buy
Phantom Shares
A-Award
Kim Tony
Portfolio Manager
Other 29 271
Value: $195.5K
Dec 19, 2025
Sell
Common Stock
S-Sale
Fairbairn Robert W
Director
Director 1
Value: $5
Dec 18, 2025
Sell
Common Stock
S-Sale
Fairbairn Robert W
Director
Director 21 936
Value: $143.0K
Jul 09, 2025
Sell
Common Stock
J-Other
Saba Capital Management, L.p.
10 Percent Owner
10% Owner 60 675 395
Value: $0.45B
Jul 09, 2025
Sell
Common Stock
J-Other
Saba Capital Management, L.p.
10 Percent Owner
10% Owner 60 675 395
Value: $0.45B
May 08, 2025
Buy
Common Stock
Minar Stephen Thomas
Vice President
CEO / President 0
Value: $0
May 08, 2025
Buy
Common Stock
Minar Stephen Thomas
Vice President
CEO / President 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BROOKLYN IMMUNOTHERAPEUTICS INC
Brooklyn Immunotherapeutics
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics,...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE